These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11212592)

  • 1. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
    Blier P; Abbott FV
    J Psychiatry Neurosci; 2001 Jan; 26(1):37-43. PubMed ID: 11212592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in the field of antidepressants, where do we go now?
    Artigas F
    Eur Neuropsychopharmacol; 2015 May; 25(5):657-70. PubMed ID: 23706576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of mood and anxiety disorders in headache patients.
    Griffith JL; Razavi M
    Headache; 2006 Oct; 46 Suppl 3():S133-41. PubMed ID: 17034391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
    Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ
    Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressant medication in children].
    Benarous X; Consoli A; Cohen D
    Rev Prat; 2020 May; 70(5):496-501. PubMed ID: 33058633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant drugs: additional clinical uses.
    Orsulak PJ; Waller D
    J Fam Pract; 1989 Feb; 28(2):209-16. PubMed ID: 2644393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants: current concepts of mode of action.
    Cowen PJ
    Int Clin Psychopharmacol; 1990 Jul; 5 Suppl 3():45-55. PubMed ID: 2172364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 ligands in the treatment of anxiety and depression.
    Quesseveur G; Nguyen HT; Gardier AM; Guiard BP
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1701-25. PubMed ID: 22917059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders.
    Ogren SO; Razani H; Elvander-Tottie E; Kehr J
    Physiol Behav; 2007 Sep; 92(1-2):172-9. PubMed ID: 17585970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders.
    Grinchii D; Dremencov E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis.
    Casucci G; Villani V; Finocchi C
    Neurol Sci; 2010 Jun; 31 Suppl 1():S99-101. PubMed ID: 20464595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of serotonin and noradrenaline in anxiety.
    Blier P; El Mansari M
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():16-23. PubMed ID: 24926868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in the neurobiology and pharmacology of affective disorders.
    LasoĊ„ W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.